Plain-English translation of NCT07726056 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial investigates how cardiac ablation—a procedure that treats irregular heart rhythms—affects athletic performance in endurance athletes with atrial fibrillation. Researchers want to understand whether this treatment helps athletes return to training and competition safely, and how it impacts their long-term fitness and performance. The study will follow 100 endurance athletes who receive the procedure and track their training and athletic outcomes over time.
Endurance athletes with atrial fibrillation face a difficult choice: medications often cause fatigue and reduce performance, while the benefits and risks of the heart rhythm procedure in athletic populations are not well understood. This trial exists to fill that gap by studying how the treatment actually affects athletes' ability to train, compete, and maintain their fitness.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive cardiac ablation—a procedure to treat your atrial fibrillation. The researchers will then monitor your training and athletic performance using the data you already share (or start sharing) through your training apps, following you over time to see how the procedure affects your ability to train, your fitness level, and your return to competition. You will likely have follow-up appointments with the research team to discuss your recovery and performance.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Australia
Belgium